NeuroBo Pharmaceuticals Receives First Site IRB Approval for Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Stock Information for Arcturus Therapeutics Holdings Inc.
Loading
Please wait while we load your information from QuoteMedia.